ANG and amyotrophic lateral sclerosis: The resulting models confirm that the loss of ANG variant's ribonuclease activity and stability contributes to ALS pathogenesis and confirm that ANG replacement is a valid pre-symptomatic treatment strategy, but contraindicate the use of ANG replacement following the clinical diagnosis of ALS symptoms.